{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:12:56Z","timestamp":1790856776710,"version":"4.1.0"},"reference-count":150,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Systemic lupus erythematosus (SLE) and other autoimmune diseases are propelled by immune dysregulation and pathogenic, disease-specific autoantibodies. Autoimmunity against the lupus autoantigen Sm is associated with cross-reactivity to Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA-1). Additionally, EBV latent membrane protein-1 (LMP1), initially noted for its oncogenic activity, is an aberrantly active functional mimic of the B cell co-stimulatory molecule CD40. Mice expressing a transgene (Tg) for the mCD40-LMP1 hybrid molecule (containing the cytoplasmic tail of LMP1) have mild autoantibody production and other features of immune dysregulation by 2\u20133 months of age, but no overt autoimmune disease. This study evaluates whether exposure to the EBV molecular mimic, EBNA-1, stimulates antigen-specific and concurrently-reactive humoral and cellular immunity, as well as lupus-like features. After immunization with EBNA-1, mCD40-LMP1 Tg mice exhibited enhanced, antigen-specific, cellular and humoral responses compared to immunized WT congenic mice. EBNA-1 specific proliferative and inflammatory cytokine responses, including IL-17 and IFN-\u03b3, were significantly increased (<jats:italic>p&amp;lt;0.0001<\/jats:italic>) in mCD40-LMP1 Tg mice, as well as antibody responses to amino- and carboxy-domains of EBNA-1. Of particular interest was the ability of mCD40-LMP1 to drive EBNA-1 associated molecular mimicry with the lupus-associated autoantigen, Sm. EBNA-1 immunized mCD40-LMP1 Tg mice exhibited enhanced proliferative and cytokine cellular responses (p&amp;lt;0.0001) to the EBNA-1 homologous epitope PPPGRRP and the Sm B\/B\u2019 cross-reactive sequence PPPGMRPP. When immunized with the SLE autoantigen Sm, mCD40-LMP1 Tg mice again exhibited enhanced cellular and humoral immune responses to both Sm and EBNA-1. Cellular immune dysregulation with EBNA-1 immunization in mCD40-LMP1 Tg mice was accompanied by enhanced splenomegaly, increased serum blood urea nitrogen (BUN) and creatinine levels, and elevated anti-dsDNA and antinuclear antibody (ANA) levels (<jats:italic>p&amp;lt;0.0001<\/jats:italic>compared to mCD40 WT mice). However, no evidence of immune-complex glomerulonephritis pathology was noted, suggesting that a combination of EBV and genetic factors may be required to drive lupus-associated renal disease. These data support that the expression of LMP1 in the context of EBNA-1 may interact to increase immune dysregulation that leads to pathogenic, autoantigen-specific lupus inflammation.<\/jats:p>","DOI":"10.3389\/fimmu.2020.606936","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T05:55:16Z","timestamp":1612331716000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity"],"prefix":"10.3389","volume":"11","author":[{"given":"Melissa E.","family":"Munroe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jourdan R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy F.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Stunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail A.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.047","article-title":"Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype","volume":"146","author":"Slight-Webb","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40004","article-title":"Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features","volume":"69","author":"Munroe","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.06.001","article-title":"Dysregulation of Innate and Adaptive Serum Mediators Precedes Systemic Lupus Erythematosus Classification and Improves Prognostic Accuracy of Autoantibodies","volume":"74","author":"Lu","year":"2016","journal-title":"J Autoimmun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208140","article-title":"Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification","volume":"75","author":"Munroe","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"8590","DOI":"10.1038\/s41598-019-45135-w","article-title":"Immunologic findings precede rapid lupus flare after transient steroid therapy","volume":"9","author":"Lu","year":"2019","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.12.005","article-title":"Pathways of impending disease flare in African-American systemic lupus erythematosus patients","volume":"78","author":"Munroe","year":"2017","journal-title":"J Autoimmun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/art.38573","article-title":"Pro-inflammatory adaptive cytokines and shed tumor necrosis factor receptors are elevated preceding systemic lupus erythematosus disease flare","volume":"66","author":"Munroe","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205171","article-title":"Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort","volume":"74","author":"Bruce","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nm1167","article-title":"Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry","volume":"11","author":"McClain","year":"2005","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12417","article-title":"The effect of cell death in the initiation of lupus nephritis","volume":"179","author":"Fenton","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.06.007","article-title":"Concordance of autoimmune disease in a nationwide Danish systemic lupus erythematosus twin cohort","volume":"47","author":"Ulff-Moller","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216227","article-title":"High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus","volume":"79","author":"Reid","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1038\/ncomms16021","article-title":"Transancestral mapping and genetic load in systemic lupus erythematosus","volume":"8","author":"Langefeld","year":"2017","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/cells8101180","article-title":"Update on the Genetics of Systemic Lupus Erythematosus: Genome-Wide Association Studies and Beyond","volume":"8","author":"Kwon","year":"2019","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000411","article-title":"Genetic advances in systemic lupus erythematosus: an update","volume":"29","author":"Chen","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215361","article-title":"Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals","volume":"78","author":"Jog","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320940029","article-title":"Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity","volume":"29","author":"Aygun","year":"2020","journal-title":"Lupus"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/art.21682","article-title":"An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus","volume":"54","author":"McClain","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24904","article-title":"Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile","volume":"90","author":"Chougule","year":"2018","journal-title":"J Med Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283535801","article-title":"Lupus and Epstein-Barr","volume":"24","author":"James","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00127","article-title":"Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders","volume":"9","author":"Dugan","year":"2019","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22834-1_4","article-title":"The Latent Membrane Protein 1 (LMP1)","volume":"391","author":"Kieser","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e02624","DOI":"10.1016\/j.heliyon.2019.e02624","article-title":"The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies","volume":"5","author":"Chatterjee","year":"2019","journal-title":"Heliyon"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2018.11.004","article-title":"Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology","volume":"75","author":"Klein","year":"2018","journal-title":"Leuk Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01718-16","article-title":"Epstein-Barr Virus LMP1-Mediated Oncogenicity","volume":"91","author":"Wang","year":"2017","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/BOR.0000000000000289","article-title":"How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases","volume":"28","author":"Draborg","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"535738","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/08916930802024772","article-title":"Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases","volume":"41","author":"Niller","year":"2008","journal-title":"Autoimmunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2017.18.2.523","article-title":"Correlation between Epstein-Barr Virus Infection and Disease Activity of Systemic Lupus Erythematosus: a Cross-Sectional Study","volume":"18","author":"Piroozmand","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/ar1181","article-title":"Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood","volume":"6","author":"Moon","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.12.008","article-title":"Aberrant Epstein-Barr viral infection in systemic lupus erythematosus","volume":"8","author":"Poole","year":"2009","journal-title":"Autoimmun Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317753069","article-title":"Epstein-Barr virus infection and type I interferon signature in patients with systemic lupus erythematosus","volume":"27","author":"Han","year":"2018","journal-title":"Lupus"},{"key":"B35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/08916930500484849","article-title":"Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus","volume":"39","author":"Poole","year":"2006","journal-title":"Autoimmunity"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00013-12","article-title":"Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection","volume":"86","author":"Sivachandran","year":"2012","journal-title":"J Virol"},{"key":"B37","article-title":"The expression of EBV-encoded LMP1 in young patients with lupus nephritis","volume":"8","author":"Ding","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2012.665944","article-title":"Epstein-Barr virus early antigen diffuse (EBV-EA\/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients","volume":"41","author":"Draborg","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e000214","DOI":"10.1136\/lupus-2017-000214","article-title":"Strong viral associations with SLE among Filipinos","volume":"4","author":"Vista","year":"2017","journal-title":"Lupus Sci Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2014.09.014","article-title":"Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses","volume":"195","author":"Cuomo","year":"2015","journal-title":"Virus Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e9599","DOI":"10.1371\/journal.pone.0009599","article-title":"60 kD Ro and nRNP A frequently initiate human lupus autoimmunity","volume":"5","author":"Heinlen","year":"2010","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e14488","DOI":"10.1371\/journal.pone.0014488","article-title":"Antibodies elicited in response to EBNA-1 may cross-react with dsDNA","volume":"6","author":"Yadav","year":"2011","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.119","article-title":"Mapping an epitope in EBNA-1 that is recognized by monoclonal antibodies to EBNA-1 that cross-react with dsDNA","volume":"4","author":"Yadav","year":"2016","journal-title":"Immun Inflamm Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2004.06.001","article-title":"Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies","volume":"23","author":"Sundar","year":"2004","journal-title":"J Autoimmun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12985-019-1137-5","article-title":"The Epstein-Barr virus EBNA1 protein modulates the alternative splicing of cellular genes","volume":"16","author":"Boudreault","year":"2019","journal-title":"Virol J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.1.187","article-title":"Sm protein-Sm site RNA interactions within the inner ring of the spliceosomal snRNP core structure","volume":"20","author":"Urlaub","year":"2001","journal-title":"EMBO J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1038\/emm.2014.84","article-title":"Epstein-Barr virus latent genes","volume":"47","author":"Kang","year":"2015","journal-title":"Exp Mol Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nri2527","article-title":"Antiviral immune responses: triggers of or triggered by autoimmunity","volume":"9","author":"Munz","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e85422","DOI":"10.1371\/journal.pone.0085422","article-title":"Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes","volume":"9","author":"Dunmire","year":"2014","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10385","article-title":"Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1","volume":"70","author":"McClain","year":"2003","journal-title":"J Med Virol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.3.1145","article-title":"Cutting edge: molecular mechanisms of synergy between CD40 and the B cell antigen receptor: role for TNF receptor-associated factor 2 in receptor interaction","volume":"169","author":"Haxhinasto","year":"2002","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310628200","article-title":"Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation","volume":"279","author":"Haxhinasto","year":"2004","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12026-014-8523-2","article-title":"Toll-like receptors and B cells: functions and mechanisms","volume":"59","author":"Buchta","year":"2014","journal-title":"Immunol Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-138925","article-title":"A novel polymorphism of the human CD40 receptor with enhanced function","volume":"112","author":"Peters","year":"2008","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737602","article-title":"TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation","volume":"38","author":"Vanden Bush","year":"2008","journal-title":"Eur J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-018-0712-y","article-title":"Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation","volume":"41","author":"Souyris","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12026-012-8270-1","article-title":"TLR7 and TLR9 in SLE: when sensing self goes wrong","volume":"53","author":"Celhar","year":"2012","journal-title":"Immunol Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.smim.2006.12.005","article-title":"Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors","volume":"19","author":"Christensen","year":"2007","journal-title":"Semin Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e42478","DOI":"10.1371\/journal.pone.0042478","article-title":"Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1","volume":"7","author":"Arcipowski","year":"2012","journal-title":"PLoS One"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903786106","article-title":"TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40","volume":"106","author":"Kraus","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900442","article-title":"Roles of the TRAF2\/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1","volume":"183","author":"Graham","year":"2009","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M502511200","article-title":"LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3","volume":"280","author":"Wu","year":"2005","journal-title":"J Biol Chem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031255","article-title":"Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes","volume":"199","author":"Xie","year":"2004","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.9.5546","article-title":"Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1","volume":"173","author":"Xie","year":"2004","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxt052","article-title":"TRAF6 is a critical regulator of LMP1 functions in vivo","volume":"26","author":"Arcipowski","year":"2014","journal-title":"Int Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201821","article-title":"TRAF binding is required for a distinct subset of in vivo B cell functions of the oncoprotein LMP1","volume":"189","author":"Arcipowski","year":"2012","journal-title":"J Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0904065","article-title":"Latent Membrane Protein 1, the EBV-Encoded Oncogenic Mimic of CD40, Accelerates Autoimmunity in B6.Sle1 Mice","volume":"185","author":"Peters","year":"2010","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.2.753","article-title":"Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis","volume":"179","author":"Munroe","year":"2007","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.07.008","article-title":"Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture","volume":"21","author":"Stunz","year":"2004","journal-title":"Immunity"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/cells1030617","article-title":"How human tumor viruses make use of autophagy","volume":"1","author":"Pratt","year":"2012","journal-title":"Cells"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1006\/scbi.2001.0412","article-title":"Role of LMP1 in immune control of EBV infection","volume":"11","author":"Pai","year":"2001","journal-title":"Semin Cancer Biol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.8.943","article-title":"Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1)","volume":"193","author":"Brown","year":"2001","journal-title":"J Exp Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.7.4645","article-title":"A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling","volume":"179","author":"Rowland","year":"2007","journal-title":"J Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306708200","article-title":"Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling","volume":"278","author":"Hostager","year":"2003","journal-title":"J Biol Chem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.9.5388","article-title":"Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling","volume":"176","author":"Xie","year":"2006","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.11.6307","article-title":"Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation","volume":"162","author":"Hostager","year":"1999","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e1004890","DOI":"10.1371\/journal.ppat.1004890","article-title":"TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation","volume":"11","author":"Greenfeld","year":"2015","journal-title":"PLoS Pathog"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.2.1316-1328.2003","article-title":"TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40","volume":"77","author":"Eliopoulos","year":"2003","journal-title":"J Virol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.20.5678","article-title":"TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1","volume":"20","author":"Schultheiss","year":"2001","journal-title":"EMBO J"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-70630-6_14","article-title":"LMP1 TRAFficking activates growth and survival pathways","volume":"597","author":"Soni","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2136756100","article-title":"Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6","volume":"100","author":"Luftig","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809933105","article-title":"IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3","volume":"105","author":"Song","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R","article-title":"Collagen-induced arthritis in C57BL\/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis","volume":"30","author":"Campbell","year":"2000","journal-title":"Eur J Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2008.08.007","article-title":"Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments","volume":"31","author":"Poole","year":"2008","journal-title":"J Autoimmun"},{"key":"B87","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.148.7.2074","article-title":"Linear epitope mapping of an Sm B\/B\u2019 polypeptide","volume":"148","author":"James","year":"1992","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00932.x","article-title":"Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1","volume":"237","author":"Graham","year":"2010","journal-title":"Immunol Rev"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.2014010041","article-title":"Latent membrane protein 1 and the B lymphocyte-a complex relationship","volume":"34","author":"Stunz","year":"2014","journal-title":"Crit Rev Immunol"},{"key":"B90","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.1.502","article-title":"A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice","volume":"160","author":"James","year":"1998","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1998.0227","article-title":"A limited lupus anti-spliceosomal response targets a cross-reactive, proline-rich motif","volume":"11","author":"Arbuckle","year":"1998","journal-title":"J Autoimmun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1186\/s13063-018-3076-7","article-title":"Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial","volume":"19","author":"Olsen","year":"2018","journal-title":"Trials"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802317","article-title":"T-independent antibody responses to T-dependent antigens: a novel follicular dendritic cell-dependent activity","volume":"182","author":"El Shikh","year":"2009","journal-title":"J Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.290.5489.89","article-title":"T-Independent immune response: new aspects of B cell biology","volume":"290","author":"Fagarasan","year":"2000","journal-title":"Science"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2005.04.005","article-title":"The role of APRIL and BAFF in lymphocyte activation","volume":"17","author":"Schneider","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v32.i4.50","article-title":"Cross-reactivity of T cells and its role in the immune system","volume":"32","author":"Petrova","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e0147567","DOI":"10.1371\/journal.pone.0147567","article-title":"Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis","volume":"11","author":"Tschochner","year":"2016","journal-title":"PLoS One"},{"key":"B98","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.09.011","article-title":"Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis","author":"Lossius","year":"2011","journal-title":"J Neuroimmunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072397","article-title":"EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2","volume":"205","author":"Lunemann","year":"2008","journal-title":"J Exp Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl067","article-title":"Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis","volume":"129","author":"Lunemann","year":"2006","journal-title":"Brain"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1038\/cti.2016.87","article-title":"Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis","volume":"6","author":"Pender","year":"2017","journal-title":"Clin Transl Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a841e4","article-title":"Epstein-Barr virus in oral shedding of children with multiple sclerosis","volume":"81","author":"Yea","year":"2013","journal-title":"Neurology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e000015","DOI":"10.1136\/lupus-2014-000015","article-title":"Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients","volume":"1","author":"Draborg","year":"2014","journal-title":"Lupus Sci Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.2.1287","article-title":"Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus","volume":"172","author":"Kang","year":"2004","journal-title":"J Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.11.6599","article-title":"EBV and systemic lupus erythematosus: a new perspective","volume":"174","author":"Gross","year":"2005","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.63","article-title":"Genetics of SLE: evidence from mouse models","volume":"6","author":"Morel","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"B107","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.158.12.6019","article-title":"Functional dissection of systemic lupus erythematosus using congenic mouse strains","volume":"158","author":"Morel","year":"1997","journal-title":"J Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.12.6670","article-title":"Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains","volume":"97","author":"Morel","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2014.1578","article-title":"The expression of renal Epstein-Barr virus markers in patients with lupus nephritis","volume":"7","author":"Yu","year":"2014","journal-title":"Exp Ther Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2005.11.003","article-title":"Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1","volume":"104","author":"Kis","year":"2006","journal-title":"Immunol Lett"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06829-11","article-title":"Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells","volume":"86","author":"Salamon","year":"2012","journal-title":"J Virol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e43317","DOI":"10.1371\/journal.pone.0043317","article-title":"Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1","volume":"7","author":"Valente","year":"2012","journal-title":"PLoS One"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511884200","article-title":"The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production","volume":"281","author":"Xu","year":"2006","journal-title":"J Biol Chem"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1406","article-title":"Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome","volume":"106","author":"Chuang","year":"2005","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01122-07","article-title":"Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus","volume":"81","author":"Martin","year":"2007","journal-title":"J Virol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.7.4139-4148.2003","article-title":"A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus","volume":"77","author":"Chen","year":"2003","journal-title":"J Virol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401720","article-title":"B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers","volume":"193","author":"Soni","year":"2014","journal-title":"J Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004100820","article-title":"Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells","volume":"16","author":"Patole","year":"2005","journal-title":"J Am Soc Nephrol JASN"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9887-0","article-title":"Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation","volume":"33","author":"Chauhan","year":"2013","journal-title":"J Clin Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2650","article-title":"U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7","volume":"107","author":"Savarese","year":"2006","journal-title":"Blood"},{"key":"B121","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00296-010-1573-4","article-title":"Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study","volume":"32","author":"Esen","year":"2012","journal-title":"Rheumatol Int"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew427","article-title":"Pathways leading to an immunological disease: systemic lupus erythematosus","volume":"56","author":"Zharkova","year":"2017","journal-title":"Rheumatol (Oxford)"},{"key":"B123","doi-asserted-by":"publisher","first-page":"796","DOI":"10.4049\/jimmunol.1901175","article-title":"Type II but Not Type I IFN Signaling Is Indispensable for TLR7-Promoted Development of Autoreactive B Cells and Systemic Autoimmunity","volume":"204","author":"Chodisetti","year":"2020","journal-title":"J Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.41641","article-title":"IFNgamma induces epigenetic programming of human T-bet(hi) B cells and promotes TLR7\/8 and IL-21 induced differentiation","volume":"8","author":"Zumaquero","year":"2019","journal-title":"Elife"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20122798","article-title":"Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells","volume":"210","author":"Giltiay","year":"2013","journal-title":"J Exp Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202195","article-title":"B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice","volume":"189","author":"Hwang","year":"2012","journal-title":"J Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00280-18","article-title":"Transmembrane Domains Mediate Intra- and Extracellular Trafficking of Epstein-Barr Virus Latent Membrane Protein 1","volume":"92","author":"Nkosi","year":"2018","journal-title":"J Virol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01310-13","article-title":"Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells","volume":"87","author":"Nanbo","year":"2013","journal-title":"J Virol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-019-02605-w","article-title":"Follicular dendritic cells display microvesicle-associated LMP1 in reactive germinal centers of EBV+ classic Hodgkin lymphoma","volume":"475","author":"Uccini","year":"2019","journal-title":"Virchows Arch"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2506","article-title":"LMP1-positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling","volume":"8","author":"Zhang","year":"2019","journal-title":"Cancer Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00589-20","article-title":"Epstein-Barr Virus LMP1 Promotes Syntenin-1- and Hrs-Induced Extracellular Vesicle Formation for Its Own Secretion To Increase Cell Proliferation and Migration","volume":"11","author":"Nkosi","year":"2020","journal-title":"mBio"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302068","article-title":"Exosomes derived from Burkitt\u2019s lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells","volume":"192","author":"Gutzeit","year":"2014","journal-title":"J Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1476-4598-9-184","article-title":"Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition","volume":"9","author":"Hannigan","year":"2010","journal-title":"Mol Cancer"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22822-8_9","article-title":"Infectious Mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06765.x","article-title":"CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission","volume":"139","author":"Marshall","year":"2007","journal-title":"Br J Haematol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e0120710","DOI":"10.1371\/journal.pone.0120710","article-title":"Distribution, persistence and interchange of Epstein-Barr virus strains among PBMC, plasma and saliva of primary infection subjects","volume":"10","author":"Kwok","year":"2015","journal-title":"PLoS One"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.4.1665-1674.2004","article-title":"Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus","volume":"78","author":"Nakayama","year":"2004","journal-title":"J Virol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10238-018-0535-0","article-title":"The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis","volume":"19","author":"Li","year":"2019","journal-title":"Clin Exp Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/978-1-4419-8216-2_7","article-title":"Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease","volume":"711","author":"Niller","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"B140","article-title":"Mechanistic insights into environmental and genetic risk factors for systemic lupus erythematosus","volume":"11","author":"Pan","year":"2019","journal-title":"Am J Transl Res"},{"key":"B141","article-title":"Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors","volume":"33","author":"Asanuma","year":"2006","journal-title":"J Rheumatol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24370","article-title":"Associations between Smoking and Systemic Lupus Erythematosus (SLE)-Related Cytokines and Chemokines among US Female Nurses","author":"Hahn","year":"2020","journal-title":"Arthritis Care Res"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.039438","article-title":"Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus","volume":"65","author":"Freemer","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B144","doi-asserted-by":"publisher","first-page":"102393","DOI":"10.1016\/j.autrev.2019.102393","article-title":"Impact of tobacco smoking upon disease risk, activity and therapeutic response in systemic lupus erythematosus: A systematic review and meta-analysis","volume":"18","author":"Parisis","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B145","doi-asserted-by":"publisher","first-page":"102291","DOI":"10.1016\/j.jaut.2019.06.002","article-title":"Ultraviolet light induces increased T cell activation in lupus-prone mice via type I IFN-dependent inhibition of T regulatory cells","volume":"103","author":"Wolf","year":"2019","journal-title":"J Autoimmun"},{"key":"B146","first-page":"191","article-title":"The initiation of autoimmunity at epithelial surfaces: a focus on rheumatoid arthritis and systemic lupus erythematosus","volume":"24","author":"Pentony","year":"2017","journal-title":"Discov Med"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02428","article-title":"Blue and Long-Wave Ultraviolet Light Induce in vitro Neutrophil Extracellular Trap (NET) Formation","volume":"10","author":"Neubert","year":"2019","journal-title":"Front Immunol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"102420","DOI":"10.1016\/j.jaut.2020.102420","article-title":"Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice","volume":"108","author":"Johnson","year":"2020","journal-title":"J Autoimmun"},{"key":"B149","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10020-019-0102-5","article-title":"Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus","volume":"25","author":"Ma","year":"2019","journal-title":"Mol Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1002\/art.40935","article-title":"Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients","volume":"71","author":"Ogunrinde","year":"2019","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.606936\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T03:41:54Z","timestamp":1697773314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.606936\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":150,"alternative-id":["10.3389\/fimmu.2020.606936"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.606936","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"article-number":"606936"}}